These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
59 related items for PubMed ID: 1378925
1. Neutralization of bleomycin hydrolase by an epitope-specific antibody. Morris G, Mistry JS, Jani JP, Mignano JE, Sebti SM, Lazo JS. Mol Pharmacol; 1992 Jul; 42(1):57-62. PubMed ID: 1378925 [Abstract] [Full Text] [Related]
2. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin. Lazo JS, Braun ID, Labaree DC, Schisselbauer JC, Meandzija B, Newman RA, Kennedy KA. Cancer Res; 1989 Jan 01; 49(1):185-90. PubMed ID: 2461797 [Abstract] [Full Text] [Related]
4. Synthesis and evaluation of fluoromycin: a novel fluorescence-labeled derivative of talisomycin S10b. Mistry JS, Jani JP, Morris G, Mujumdar RB, Reynolds IJ, Sebti SM, Lazo JS. Cancer Res; 1992 Feb 01; 52(3):709-18. PubMed ID: 1370650 [Abstract] [Full Text] [Related]
5. Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family. Sebti SM, Mignano JE, Jani JP, Srimatkandada S, Lazo JS. Biochemistry; 1989 Aug 08; 28(16):6544-8. PubMed ID: 2477059 [Abstract] [Full Text] [Related]
6. Bleomycin hydrolase activity and cytotoxicity in human tumors. Lazo JS, Boland CJ, Schwartz PE. Cancer Res; 1982 Oct 08; 42(10):4026-31. PubMed ID: 6179595 [Abstract] [Full Text] [Related]
7. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA. Wassermann K, Zwelling LA, Lown JW, Hartley JA, Nishikawa K, Lin JR, Newman RA. Cancer Res; 1990 Mar 15; 50(6):1732-7. PubMed ID: 1689610 [Abstract] [Full Text] [Related]
8. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin. Sebti SM, Jani JP, Mistry JS, Gorelik E, Lazo JS. Cancer Res; 1991 Jan 01; 51(1):227-32. PubMed ID: 1703034 [Abstract] [Full Text] [Related]
13. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. He Q, Skog S, Wang N, Eriksson S, Tribukait B. Eur J Cell Biol; 1996 Jun 01; 70(2):117-24. PubMed ID: 8793383 [Abstract] [Full Text] [Related]
14. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck. Eura M, Chikamatsu K, Katsura F, Obata A, Sobao Y, Takiguchi M, Song Y, Appella E, Whiteside TL, DeLeo AB. Clin Cancer Res; 2000 Mar 01; 6(3):979-86. PubMed ID: 10741724 [Abstract] [Full Text] [Related]
16. Substrate specificity of bleomycin hydrolase. Sebti SM, DeLeon JC, Ma LT, Hecht SM, Lazo JS. Biochem Pharmacol; 1989 Jan 01; 38(1):141-7. PubMed ID: 2462878 [Abstract] [Full Text] [Related]
17. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies. Chen Z, Van Kampen V, Raulf-Heimsoth M, Baur X. Clin Exp Allergy; 1996 Apr 01; 26(4):406-15. PubMed ID: 8732237 [Abstract] [Full Text] [Related]
18. Purification of bleomycin hydrolase with a monoclonal antibody and its characterization. Nishimura C, Tanaka N, Suzuki H, Tanaka N. Biochemistry; 1987 Mar 24; 26(6):1574-8. PubMed ID: 3109467 [Abstract] [Full Text] [Related]